Jefferson researchers develop COVID-19 vaccine candidate, in talks with manufacturer

Researchers at Thomas Jefferson University said Tuesday they have developed a COVID-19 vaccine candidate, as nearly 1.4 million cases of the virus have been confirmed across the world. Matthias Schnell, director of the Jefferson Vaccine Center in Philadelphia, said Coravax is made from part of the current coronavirus, which is combined with another proven vaccine that serves as a carrier. “The benefit is that the ‘carrier’ vaccine has already been rigorously tested, and s hown to be safe…
Source: Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news

Related Links:

British drugmaker AstraZeneca has doubled manufacturing capacity for its potential coronavirus vaccine to 2 billion doses in two deals involving Microsoft billionaire Bill Gates that guarantee early supply to lower-income countries.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news
I, for one, am taking social distancing seriously. My husband and I haven’t had sex since the quarantine began. We’ve only hugged each other three times. A two-time cancer survivor, I’m afraid I’ll catch COVID-19. I’ve been working at home, but he’s been going in, and I think he’s afraid he’ll spread the disease. Not that he has it. We’re quite a pair. We always stand six feet apart. This pandemic is hard on me because I have no frame of reference for it. All I know is that danger is all around me. My mother taught me about danger when I was two and a half. We lived alo...
Source: World of Psychology - Category: Psychiatry & Psychology Authors: Tags: Personal Trauma Cancer Survivor coronavirus COVID-19 Rape Sexual Assault social distancing Source Type: blogs
On first glance, today’s U.S. jobs report seems like a much-needed dose of good news when more or less everything else is aflame: Unemployment fell from 14.7% to 13.3% in May as the economy gained 2.5 million jobs; economists had expected the rate to increase to as much as 20%. Any drop in unemployment is, of course, a welcome development. But there are at least three big reasons why we should take pause before cracking out the champagne over Friday’s jobs numbers. First, and most saliently given the ongoing protests over justice and equality, this rebound isn’t being felt equally across demographic group...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 UnitedWeRise20Disaster Source Type: news
Japan aims to put coronavirus vaccines into use by June 2021, the health minister said on Friday, as the country strives to be fully ready to host the Tokyo Olympics, originally planned for this summer but postponed by one year due to the pandemic.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Authors: Prajapati S, Sharma M, Kumar A, Gupta P, Narasimha Kumar GV Abstract In the 21st century, human civilization has witnessed three major epidemics caused by Coronaviruses namely severe acute respiratory syndrome coronavirus (SARS CoV) in 2003, Middle East respiratory syndrome coronavirus (MERS CoV) in 2012 and 2019 novel coronavirus (2019 nCoV) or coronavirus disease (COVID 19) in 2019. Among these, COVID-19 has greater transmission and mortality rate. 2019 nCoV belongs to a large family of positive sense single-stranded RNA viruses (+ssRNA) that can be isolated in different animal species. The most communal...
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
AstraZeneca says it could provide two billion doses of a potential vaccine, helped by backing from Bill Gates.
Source: BBC News | Health | UK Edition - Category: Consumer Health News Source Type: news
[New Times] President Paul Kagame has said that the world cannot accept the new coronavirus pandemic to cause double damage, calling on leaders from different sectors to support efforts aimed at developing needed vaccines.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
[Thomson Reuters Foundation] Rome -Thursday's GAVI vaccine summit aims to help people in the developing world get access to any eventual coronavirus vaccine. What are the obstacles?
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
The director of the National Institutes of Health said Thursday he's concerned that vaccine "skepticism" could hinder the effort to immunize the country against Covid-19.
Source: - Health - Category: Consumer Health News Source Type: news
Drugmakers around the world are rushing to develop a treatment or vaccine for the fast-spreading novel coronavirus that has killed over 390,000 people and ravaged financial markets. Two other Indian companies, Glenmark Pharmaceuticals Ltd and Strides Pharma Science Ltd, are also conducting trials in India for potential COVID-19 treatments.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Coronavirus | COVID-19 | Health Management | Vaccines